Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. May 6, 2013; 4(2): 28-38
Published online May 6, 2013. doi: 10.4292/wjgpt.v4.i2.28
Published online May 6, 2013. doi: 10.4292/wjgpt.v4.i2.28
Treatments | SIT (%) | GE (%) |
Normal control (citrate buffer) | 56.61 ± 2.58 | 72.50 ± 1.68 |
Diabetic control (streptozotocin 100 mg/kg) | 76.90 ± 6.12a | 55.23 ± 9.30a |
Insulin (2 IU/kg s.c.) | 61.05 ± 3.85c | 95.87 ± 2.41ac |
Metoclopramide (20 mg/kg p.o.) | 50.04 ± 2.42ce | 76.38 ± 7.67ce |
Insulin (2 IU/kg s.c.) +Metoclopramide (20 mg/kg p.o.) | 54.30 ± 3.46c | 94.91 ± 1.01ac |
Domperidone (20 mg/kg p.o.) | 48.70 ± 4.53ce | 90.92 ± 4.92ac |
Insulin (2 IU/kg s.c.) +Domperidone (20 mg/kg p.o.) | 62.60 ± 3.07c | 92.87 ± 1.14ac |
Erythromycin (6 mg/kg p.o.) | 43.05 ± 3.50ce | 84.77 ± 2.11c |
Insulin (2 IU/kg s.c.) + | 49.14 ± 4.57ce | 90.86 ± 3.20ac |
Erythromycin (6 mg/kg p.o.) |
- Citation: Shalaby MAF, Latif HAAE, Sayed MEE. Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice. World J Gastrointest Pharmacol Ther 2013; 4(2): 28-38
- URL: https://www.wjgnet.com/2150-5349/full/v4/i2/28.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v4.i2.28